Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study.

Antzeko izenburuak

• Co-trimoxazole prophylaxis in African children with HIV-1 - Reply
  nork: Gibb, D, et al.
  Argitaratua: (2005)
• Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
  nork: Crook, A, et al.
  Argitaratua: (2016)
• Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study.
  nork: Wolbers, M, et al.
  Argitaratua: (2008)
• Can HIV treatments inform other contexts? A trial of an additional indication for co-trimoxazole prophylaxis.
  nork: Ngari, M, et al.
  Argitaratua: (2017)
• Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study.
  nork: Glass, T, et al.
  Argitaratua: (2006)